Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TCfor Thyroid Cancer6 locations incl. Washington D.C.Sponsor: Massachusetts General HospitalSex: All·Age: 12+Code: NCT05668962·Phase 2·RecruitingApply to this trial
Effectiveness of Interventions to Improve Resiliency & Burnout in Behavioral Health Residential Stafffor Burnout1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT05806112·Enrolling By Invitation
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myelomafor Multiple Myeloma13 locations incl. San FranciscoSponsor: K36 Therapeutics, Inc.Sex: All·Age: 18+Code: NCT05651932·Phase 1·RecruitingApply to this trial
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterationsfor Cancer Harboring BRAF Alterations30 locations incl. Beverly HillsSponsor: Fore BiotherapeuticsSex: All·Age: 10+Code: NCT05503797·Phase 2·RecruitingApply to this trial
APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support Systemfor Wounds and Injuries1 location in BostonSponsor: Andrew Tomas ReisnerSex: All·Age: 18+Code: NCT06121661·Phase 1·RecruitingApply to this trial
Pilot/Pivotal Study of DBS+Rehab After Strokefor Stroke10 locations incl. PhoenixSponsor: Enspire DBS Therapy, Inc.Sex: All·Age: 21+Code: NCT05701280·RecruitingApply to this trial
A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Informationfor Adult Growth Hormone Deficiency29 locations incl. PhoenixSponsor: Novo Nordisk A/SSex: All·Age: 18+Code: NCT05718570·Enrolling By Invitation
Health Opportunities and Promoters of Equitable Screening for Lung Cancerfor Lung Cancer1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 50 - 80Code: NCT05784922·RecruitingApply to this trial
Kisspeptin Administration Subcutaneously to Patients With IHHfor Hypogonadotropic Hypogonadism1 location in BostonSponsor: Stephanie B. Seminara, MDSex: All·Age: 18+Code: NCT05896293·Phase 2·RecruitingApply to this trial
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanomafor MelanomaDrug: Ipilimumab4 locations incl. Los AngelesSponsor: NYU Langone HealthSex: All·Age: 18 - 100Code: NCT05428007·Phase 2·RecruitingApply to this trial
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2for HER2-positive Breast Cancer14 locations incl. Los AngelesSponsor: Mersana TherapeuticsSex: All·Age: 18+Code: NCT05514717·Phase 1·RecruitingApply to this trial
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancerfor Breast Cancer45 locations incl. DothanSponsor: Stemline Therapeutics, Inc.Sex: All·Age: 18+Code: NCT05563220·Phase 1, Phase 2·RecruitingApply to this trial
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosisfor Multiple Sclerosis12 locations incl. New HavenSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Sex: All·Age: 18 - 55Code: NCT05285891·Phase 4·RecruitingApply to this trial
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3for Urinary Bladder Neoplasms41 locations incl. TucsonSponsor: Eli Lilly and CompanySex: All·Age: 18+Code: NCT05614739·Phase 1·RecruitingApply to this trial
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancerfor Hormone Receptor-positive Breast Cancer7 locations incl. New HavenSponsor: Ellipses PharmaSex: Female·Age: 18+Code: NCT05573126·Phase 1, Phase 2·RecruitingApply to this trial
Biology of Young Lung Cancer Study: The YOUNG LUNG Studyfor Non Small Cell Lung Cancer4 locations incl. BostonSponsor: Dana-Farber Cancer InstituteSex: All·Age: 15+Code: NCT05265429·RecruitingApply to this trial
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)for Glioblastoma2 locations incl. San FranciscoSponsor: Jasper GerritsenSex: All·Age: 18 - 90Code: NCT06146725·RecruitingApply to this trial
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)for Glioblastoma2 locations incl. San FranciscoSponsor: Jasper GerritsenSex: All·Age: 18 - 90Code: NCT06146738·RecruitingApply to this trial
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastomafor Glioblastoma, IDH-wildtype2 locations incl. San FranciscoSponsor: Erasmus Medical CenterSex: All·Age: Up to 90Code: NCT06273176·RecruitingApply to this trial
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)for Glioblastoma2 locations incl. San FranciscoSponsor: Jasper GerritsenSex: All·Age: 18 - 90Code: NCT06283927·RecruitingApply to this trial
JUPITER 4.0 - Risk Factors for Failure of Isolated Medial Patellofemoral Ligament Reconstructionfor Patellar Dislocation, Recurrent16 locations incl. Redwood CitySponsor: Hospital for Special Surgery, New YorkSex: All·Age: 10 - 35Code: NCT06883396·RecruitingApply to this trial
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemiafor Critical Limb Ischemia30 locations incl. La JollaSponsor: LimFlow, Inc.Sex: All·Age: 18 - 95Code: NCT05313165·RecruitingApply to this trial
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)for Advanced MelanomaDrug: Tebentafusp25 locations incl. PhoenixSponsor: Immunocore LtdSex: All·Age: 18+Code: NCT05549297·Phase 3·RecruitingApply to this trial
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)for Triple Negative Breast Cancer184 locations incl. BirminghamSponsor: Gilead SciencesSex: All·Age: 18+Code: NCT05633654·Phase 3·RecruitingApply to this trial
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)for High Grade Epithelial Ovarian Cancer37 locations incl. PhoenixSponsor: GenmabSex: All·Age: 18+Code: NCT05579366·Phase 1, Phase 2·RecruitingApply to this trial
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumorsfor Melanoma58 locations incl. BirminghamSponsor: PfizerSex: All·Age: 16+Code: NCT05538130·Phase 1·RecruitingApply to this trial
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsiafor Avoidant/Restrictive Food Intake Disorder1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT05587127·RecruitingApply to this trial
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)for Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)46 locations incl. ScottsdaleSponsor: Ionis Pharmaceuticals, Inc.Sex: All·Age: 18+Code: NCT05667493·Phase 3·Enrolling By Invitation
The Diabetes Prevention Program Outcomes Study AD/ADRD Projectfor Diabetes27 locations incl. PhoenixSponsor: Marinella TemprosaSex: All·Age: All ages·Accepts healthy volunteersCode: NCT05704309·Enrolling By Invitation
Surgical Pembro +/- Olaparib w TMZ for rGBMfor GlioblastomaDrug: Olaparib4 locations incl. BostonSponsor: L. Nicolas Gonzalez Castro, MD, PhDSex: All·Age: 18+Code: NCT05463848·Phase 2·RecruitingApply to this trial
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)for Atherosclerotic Cardiovascular Disease in Patients With ESKDDrug: Clazakizumab164 locations incl. DecaturSponsor: CSL BehringSex: All·Age: 18+Code: NCT05485961·Phase 2, Phase 3·RecruitingApply to this trial
Genetic Testing Decision Aidfor Epithelial Ovarian Carcinoma2 locations incl. BostonSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT05470920·RecruitingApply to this trial
Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depressionfor Major Depressive Disorder1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 18 - 70Code: NCT05450432·Phase 4·RecruitingApply to this trial
Boosting Emotional Well-being and Happiness in Outpatients Living With Diabetesfor Diabetes Mellitus, Type 21 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT05420051·RecruitingApply to this trial
Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhagefor Subarachnoid Hemorrhage, Aneurysmal1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 18 - 85Code: NCT05103566·RecruitingApply to this trial
Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgeryfor Postoperative Pain1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 18+Code: NCT04912531·RecruitingApply to this trial
A Study of EP0031 in Patients With Advanced RET-altered Malignanciesfor Advanced Solid TumorDrug: EP003118 locations incl. Los AngelesSponsor: Ellipses PharmaSex: All·Age: 18+Code: NCT05443126·Phase 1, Phase 2·RecruitingApply to this trial
Collagen-targeted PET Imaging for Early Interstitial Lung Diseasefor Interstitial Lung Disease1 location in BostonSponsor: Massachusetts General HospitalSex: All·Age: 40+Code: NCT05417776·Phase 2·RecruitingApply to this trial
A Retrospective Assessment of OviTex PRS (OviTex)for Reconstructive Surgical Procedures11 locations incl. NaplesSponsor: Tela Bio IncSex: Female·Age: 18 - 75Code: NCT05736848·RecruitingApply to this trial
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)for Prostate CancerDrug: JANX00732 locations incl. BirminghamSponsor: Janux TherapeuticsSex: Male·Age: 18 - 100Code: NCT05519449·Phase 1·RecruitingApply to this trial